LFG
ICPT

Larson Financial Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Larson Financial Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-90
Closed -$4K – 863
2020
Q2 		$4K Sell
90
-309
-77% -$23.9K ﹤0.01% 514
2020
Q1 		$25K Sell
399
-53
-12% -$4.76K 0.02% 210
2019
Q4 		$56K Sell
452
-91
-17% -$8.15K 0.03% 147
2019
Q3 		$36K Buy
543
+525
+2,917% +$35.3K 0.02% 175
2019
Q2 		$1K Buy
+18
New +$1.61K ﹤0.01% 480

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Larson Financial Group's ICPT Position: Q3 2020 in Review

Larson Financial Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 90 shares — an estimated $4K sold.

Larson Financial Group first reported a position in ICPT in Q2 2019 and held it in 5 quarters. The position peaked at $56K in Q4 2019. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • Larson Financial Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Larson Financial Group sold 90 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $4K.
  • Larson Financial Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2019 and held it in 5 quarters.
  • Larson Financial Group's Intercept Pharmaceuticals, Inc. position peaked at $56K in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Larson Financial Group's 13F filing for Q3 2020, filed 8 Oct 2020.